NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products.
NeoSync is committed to the advancement of research in this field, with completed, ongoing, and planned trials.
Through our NEST® technology, we are pioneering personalized, low energy brain stimulation for the treatment of Major Depressive Disorder and other diseases of the Central Nervous System (CNS).
Please click below if you would like to speak with someone from the company.
CAUTION: NEST® is an investigational device and limited by federal (United States) law to Investigational Use
Copyright 2013. NeoSync, Inc.. All rights reserved.